IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#2070
Positioning
Market Dominance
Retail Trade
Retail
$28M
Lei Xia
We are an offshore holding company incorporated in Cayman Islands, conducting our operation in Hong Kong and the People’s Republic of China (“PRC”) through our wholly-owned subsidiaries in Hong Kong and PRC. Our principal executive office is located at Room 3801, Building A, Sunhope e·METRO, No. 7018 Cai Tian Road, Futian District, Shenzhen, Guangdong, China, 518000, and the lease for our current office will expire in May 2025. Our registered agent in Cayman Islands is Vistra (Cayman) Limited, P. O. Box 31119 Grand Pavilion, Hibiscus Way, 802 West Bay Road, Grand Cayman, KY1-1205 Cayman Islands.
Headcount
—
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
X-AXIS: EV/EBITDA (LOWER = CHEAPER) | Y-AXIS: ROE (HIGHER = ELITE) | RED CIRCLE = IZM ANALYSIS TARGET
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$ARCO Arcos Dorados Holdings Inc. | 73 | 85 | 89 | 65 | - | - | 29.1% | 5.1% | 46.8% | 7.3% | 3.3% | 3.2% | 3.4% | 153.0x | $1.5B | VS | |
$IMKTA INGLES MARKETS INC | 70 | 73 | 89 | 76 | 11.3x | 4.1x | 5.3% | 3.3% | 23.9% | 2.2% | 1.6% | -5.4% | 1.0% | 32.0x | $1.3B | VS | |
$SGU STAR GROUP, L.P. | 69 | 82 | 79 | 63 | - | - | 26.2% | 7.8% | 31.5% | 6.4% | 4.1% | 1.0% | 6.1% | 63.0x | $399M | VS | |
$EZPW EZCORP INC | 68 | 77 | 82 | 89 | 7.2x | 4.2x | 12.0% | 6.4% | 58.6% | 11.7% | 8.6% | 9.7% | 0.0% | 51.0x | $1.2B | VS | |
$HTHT H World Group Ltd | 68 | 91 | 44 | 84 | - | - | 24.9% | 4.9% | 100.0% | 21.8% | 13.0% | 6.2% | 2.9% | 45.0x | $101.1B | VS | |
$DDL Dingdong (Cayman) Ltd | 68 | 86 | 82 | 57 | - | - | 42.4% | 4.0% | 100.0% | 0.9% | 1.3% | 12.3% | 0.0% | 201.0x | $1.2B | VS | |
$SBH Sally Beauty Holdings, Inc. | 68 | 83 | 92 | 77 | 5.1x | 2.3x | 27.5% | 6.9% | 51.6% | 8.9% | 5.3% | -0.4% | 0.0% | 177.0x | $1.6B | VS | |
$SPH SUBURBAN PROPANE PARTNERS LP | 67 | 80 | 90 | 53 | - | 13.0x | 18.6% | 4.7% | 60.7% | 14.4% | 7.4% | 7.9% | 7.1% | 202.0x | $1.2B | VS | |
$IHG INTERCONTINENTAL HOTELS GROUP PLC /NEW/ | 67 | 63 | 81 | 67 | - | - | -29.5% | 13.1% | 58.6% | 40.7% | 27.4% | 6.8% | 1.3% | - | $21.5B | VS | |
$ROST ROSS STORES, INC. | 67 | 63 | 55 | 83 | 25.2x | 16.5x | 34.8% | 13.3% | 28.0% | 11.6% | 9.1% | 10.4% | 1.0% | 26.0x | $51.6B | VS | |
$IZM ICZOOM Group Inc. | 50 | 55 | 79 | 39 | 9.6x | 3.2x | 31.0% | 11.6% | 3.3% | 0.5% | 0.6% | 5.1% | 0.0% | 95.0x | $28M | ||
| SECTOR BENCH | - | - | - | - | - | 21.4x | 9.1x | 8.9% | 2.9% | 36.2% | 3.9% | 1.6% | 3.8% | 0.0% | 0.6x | - | REF |
ICZOOM Group Inc. (IZM) receives a "Reduce" rating with a composite score of 49.6/100. It ranks #2070 out of 7,333 stocks in our coverage universe and carries a 2-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
YOY expansion rate
Core pricing power
Operating efficiency
Bottom-line conversion
Equity capital efficiency
Asset base utilization
Financial leverage load
Direct cash return
Lei Xia
Chief Executive Officer
55
49
35
Audit Verdict: Lower quality and stability scores may indicate governance concerns.
No recent insider transactions available for IZM
HQ Base
Pending Verification
Lagging peers — losers tend to keep underperforming
Trading at a discount to fundamentals — favorable entry valuation
Average quality profile
Average volatility — neutral timing signal
Moderate investment profile
Mid-range overall rating
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Retail Trade sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
Projection based on user-defined inputs. Re-calculated daily against current market data.
Reverse DCF Framework — Mauboussin Methodology
Institutional-grade Reverse DCF analysis. This model identifies the growth hurdles embedded in current market prices. When implied growth is significantly lower than historical or projected rates, a margin of safety may exist. Re-audited daily.
No analyst ratings for IZM.
View All RatingsNet income exceeding cash flow (Accrual bloat detected)
Improving capital utilization rates confirmed
| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 55 | 69 | -14DRAG |
| MOMENTUM | 39 | 37 | +2NEUTRAL |
| VALUATION | 79 | 89 | -10DRAG |
| INVESTMENT | 49 | 89 | -40DRAG |
| STABILITY | 35 | 34 | +1NEUTRAL |
| SHORT INT | 76 | 88 | -12DRAG |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROIC 3.8% vs WACC 5.1% (spread -1.3%)
GM 3% vs sector 36%, OM 1% vs sector 4%
Capital turnover 14.49x
Rev growth 5%, 3yr history
Interest coverage 2.5x, Net debt/EBITDA 6.7x
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
ICZOOM Group Inc. receives a Reduce rating from our analysis, with a composite score of 49.6/100 and 2 out of 5 stars, ranking #2070 out of 7,333 stocks. IZM's factor profile shows weakness across multiple dimensions, suggesting the stock may underperform going forward. Existing holders may want to consider trimming positions or tightening stop-losses.
With a quality score of 55/100, IZM shows adequate but unremarkable business quality. The company reports a return on equity of 31.0% (sector avg: 8.9%), gross margins of 3.3% (sector avg: 36.2%), net margins of 0.6% (sector avg: 1.6%). This suggests the company generates acceptable returns but may lack the competitive positioning or operational efficiency to stand out from peers.
IZM carries a solid value score of 79/100, pointing to an attractively priced stock relative to peers. Key valuation metrics include a P/E ratio of 9.60x, an EV/EBITDA of 3.21x, a P/B ratio of 0.76x. This score suggests reasonable compensation for the risks involved, with potential upside if the market recognizes the stock's underlying worth.
With an investment score of 49/100, IZM exhibits moderate growth-oriented spending. Key growth metrics include revenue growth of 5.1% vs. a sector average of 3.8% and a return on assets of 11.6% (sector: 2.9%). The company appears to be balancing growth investments with capital returns, though the pace of investment may not be enough to accelerate top-line growth meaningfully.
IZM is currently showing below-average momentum at 39/100, which may indicate weakening institutional interest or negative sentiment shifts. Revenue growth stands at 5.1% year-over-year, while a beta of -0.02 reflects its sensitivity to broader market moves. Investors should note that declining momentum can precede further price weakness, though contrarian opportunities sometimes emerge at these levels.
IZM's stability score of 35/100 signals elevated volatility and/or leverage concerns. Key stability metrics include a beta of -0.02 and a debt-to-equity ratio of 95.00x (sector avg: 0.6x). Investors should be prepared for wider-than-average price swings and consider position sizing accordingly to manage portfolio risk.
IZM carries a short interest score of 76/100, indicating moderate short selling activity. This is a neutral reading — not enough to signal systemic bearishness, but worth monitoring. Specific risk factors include elevated leverage (D/E: 95.00x), micro-cap liquidity risk. At $28M market cap (micro-cap), ICZOOM Group Inc. offers reasonable institutional liquidity.
ICZOOM Group Inc. is a micro-cap company in the Retail Trade sector, ranked #0 of 50 in its sector (100th percentile) and #2070 of 7,333 overall (72nd percentile). Key comparisons include ROE of 31.0% exceeding the 8.9% sector median and operating margins of 0.5% below the 3.9% sector average. This top-quartile standing reflects exceptional competitive strength relative to Retail Trade peers.
While IZM currently exhibits a REDUCE profile, superior opportunities exist within the RETAIL TRADE sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Retail Trade Alpha →Quant Factor Profile
Upgrade catalyst
Improvement in Stability (35) would have the largest impact on the composite score.
EV/EBITDA 65% BELOW SECTOR MEDIAN (FAVORABLE)
ROE 248% ABOVE SECTOR MEDIAN (FAVORABLE)
Gross Margin 91% BELOW SECTOR MEDIAN
AUDIT DATA AS OF JUN 30, 2025 (Q1 FY2025)
We rate ICZOOM Group Inc. (IZM) as a Reduce with a composite score of 49.6/100 at a current price of $0.93. The quantitative profile shows weakness across multiple dimensions, suggesting limited upside potential and elevated risk of underperformance relative to peers over the next 12 months.
The rating is primarily driven by strength in value (79th percentile) and quality (55th percentile), which together account for the majority of the composite score. Offsetting weakness in stability (35th percentile) and momentum (39th percentile) tempers our overall conviction. We assign a No Moat rating (39/100), Medium uncertainty, and Standard capital allocation.
Key items to watch: momentum to confirm whether the current price trend has legs. Any material change in these dynamics could warrant a reassessment of our rating. The moat trend is stable, which suggests the competitive landscape is stable for now.
ICZOOM Group Inc. holds a top-quartile position (#0 of 50) within the Retail Trade sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 49.6/100 places it at rank #2070 in our full 7,333-stock universe. At $28M in market capitalization, ICZOOM Group Inc. is a small-cap player in the Retail Trade space, which limits certain scale advantages but may allow for more agile strategic execution.
Revenue is growing at 5%, though momentum at the 39th percentile suggests the market has not yet fully recognized this trajectory. This potential disconnect between fundamental improvement and market recognition could represent an opportunity for patient investors if the growth trend persists.
The margin cascade tells an important story: gross margins of 3% (-32.9pp vs sector) narrow to operating margins of 1% (-3.4pp vs sector) and net margins of 0.6%, yielding a gross-to-net conversion rate of 20%. This conversion rate is typical for the sector, suggesting a standard cost structure without notable efficiency advantages or disadvantages.
At a current price of $0.93, ICZOOM Group Inc. appears undervalued relative to its fundamentals. Our value factor score of 79/100 reflects a composite assessment across multiple valuation metrics including price-to-earnings, price-to-book, EV/EBITDA, and price-to-sales ratios relative to both sector peers and the broader market. The stock screens as attractively priced on a majority of these measures, suggesting the market may be underappreciating the underlying fundamentals.
The stock currently trades at a P/E of 9.6x (a 55% discount to the sector median of 21.4x), EV/EBITDA of 3.2x (discounted to peers), P/B of 0.8x, P/S of 0.0x. The below-sector P/E suggests possible undervaluation or the market pricing in near-term headwinds.
Returns on equity of 31.0% exceed the cost of equity for most companies, indicating genuine shareholder value creation and a reinvestment engine that compounds wealth over time.
A value factor score of 79/100 suggests the market is underpricing these fundamentals, creating a potential margin of safety for new investors.
Return on assets of 11.6% indicates efficient deployment of the full asset base, not just equity capital.
The Reduce rating (composite 49.6/100) reflects multi-factor weakness, and historically, stocks in this scoring range have underperformed the market by a meaningful margin.
Thin net margins of 0.6% provide limited cushion against cost pressures, competitive pricing, or macroeconomic headwinds — even small changes in costs could swing the company to a loss.
We assign a Medium uncertainty rating to ICZOOM Group Inc.. The stock presents a balanced risk profile: below-average price stability (35th percentile) and low beta of -0.02 — while defensive, this may indicate limited upside participation in bull markets. While not risk-free, the core business fundamentals are adequate to withstand moderate economic stress, and the range of potential outcomes around our fair value estimate is manageable.
Specific risk factors that inform our assessment include: below-average price stability (35th percentile); low beta of -0.02 — while defensive, this may indicate limited upside participation in bull markets; the combination of leverage (95% D/E) and thin margins (0.6% net) amplifies downside risk. Each of these factors independently widens the distribution of potential outcomes, and in combination they create a risk profile that demands careful position sizing. The stability factor at the 35th percentile and quality factor at the 55th percentile provide a quantitative summary of the overall risk landscape.
We identify limited risk mitigants at this time, which contributes to our medium uncertainty assessment. Investors should monitor for improvement in balance sheet metrics, margin stability, and business predictability that could warrant a downgrade in our risk assessment over time.
We rate ICZOOM Group Inc.'s capital allocation as Standard. Management has shown adequate — though not exceptional — stewardship of shareholder capital. Returns on equity stand at 31.0%, and the balance sheet is managed within acceptable parameters (D/E: 95%). Exemplary allocators typically sustain ROE above 20% and D/E below 50%; ICZOOM Group Inc. falls short on at least one dimension.
There is room for improvement in optimizing the capital structure or enhancing shareholder returns. Absent a dividend, the overall capital allocation framework would benefit from either higher reinvestment returns, improved balance sheet efficiency, or increased shareholder distributions. We will monitor for signs of strategic improvement that could warrant an upgrade.
In summary, ICZOOM Group Inc. receives a Reduce rating with a composite score of 49.6/100 (rank #2070 of 7,333). Our quantitative framework assigns a No Moat (39/100, trend: stable), Medium uncertainty, and Standard capital allocation. The average factor score across quality, value, momentum, stability, and investment is 52/100.
Our analysis does not support a constructive view on ICZOOM Group Inc. at this time. The combination of limited competitive advantages, medium uncertainty, and standard capital allocation suggests unfavorable risk-reward at current levels. We recommend investors avoid new positions and existing holders consider reducing exposure.
Analysis derived from Blank Capital Research quantitative terminal. For informational purposes only. No trade solicitation. Past performance not indicative of future results. Consult a qualified advisor.
We do not assign ICZOOM Group Inc. a meaningful economic moat, scoring 39/100 on our composite assessment. The ROIC-WACC spread of -1.3% is the primary signal of economic value creation. Current fundamentals do not demonstrate the kind of durable competitive advantages — such as superior returns on invested capital, margin superiority, or reinvestment efficiency — that would protect the company from competitive erosion over the long term. The highest-scoring pillar, reinvestment efficiency, reached only 20/20.
The strongest moat sources are reinvestment efficiency (20/20) and margin superiority (8.3/20). Capital turnover 14.49x. GM 3% vs sector 36%, OM 1% vs sector 4%. These pillars form the core of ICZOOM Group Inc.'s competitive identity and are the primary drivers of excess returns in our framework.
Areas of relative weakness include economic value creation (1.7/20) and growth durability (4.4/20). ROIC 3.8% vs WACC 5.1% (spread -1.3%). Improvement in these areas could meaningfully widen the moat over time, while deterioration would be an early warning of competitive erosion.
Our moat trend assessment is Stable. Multi-year ROIC and operating margin trajectories show neither meaningful improvement nor deterioration, suggesting the competitive position is steady. We expect ICZOOM Group Inc.'s moat profile to remain largely unchanged absent a material shift in return on capital or industry dynamics.
Key profit drivers include moderate revenue growth of 5%, returns on equity of 31.0% driving shareholder value creation. The margin cascade from 3% gross to 1% operating to 0.6% net reveals the company's cost structure and reinvestment intensity. Our analysis indicates that profit quality is adequate though not exceptional, with the quality factor at the 55th percentile.
The margin profile shows gross margins of 3%, operating margins of 1%, net margins of 0.6%. Return metrics include ROE of 31.0% and ROA of 11.6%. Relative to the Retail Trade sector, gross margins are 32.9 percentage points below the sector median of 36%, and ROE of 31.0% compares to a sector median of 8.9%.
The balance sheet reflects above-average leverage with D/E of 95%, revenue growth of 5%. The sector median D/E is 1%, putting ICZOOM Group Inc. at higher leverage than the typical peer. Overall balance sheet health is adequate for the current business environment.
Elevated short interest (76th percentile) indicates that sophisticated market participants are betting against the stock.
Above 50MA
37.18%
Net New Highs
+51081

Shares of Alcoa Corporation (NYSE: AA) rose sharply in today’s pre-market trading after the company reported better-than-expected sales for its first quarter. The company reported quarterly losses of 81 cents per share, according to data from Benzinga Pro. Alcoa still sees full-year alumina production of between 9.8 million and 10 million metric tons and full-year alumina shipments between 12.7 million and 12.9 million metric tons. Alcoa shares jumped 3% to $36.60 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers Tian Ruixiang Holdings Ltd (NASDAQ: TIRX) shares gained 155.6% to $1.24 in pre-market trading after gaining around 8% on Wednesday. MicroCloud Hologram Inc. (NASDAQ: HOLO) gained 51.8% to $3.40 in pre-market trading after falling around 5% on Wednesday. Smart for Life, Inc. (NASDAQ: SMFL) shares gained 28.4% to $0.6035 in pre-market trading after gaining over 21% on Wednesday. Tantech Holdings ...

Shares of The Travelers Companies, Inc. (NYSE: TRV) fell sharply during Wednesday’s session following first-quarter earnings. Travelers reported a mixed first quarter, with earnings lagging analyst' expectations. Core income per share reached $4.69 from $4.11 a year ago, missing the $4.90 consensus forecast. Net income per share rose to $4.80 from $4.13 a year earlier. Travelers shares dipped 8.1% to $205.03 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers INVO Bioscience, Inc. (NASDAQ: INVO) shares shot up 256% to $2.78 after the company reported a year-over-year increase in fourth-quarter revenue results and said it remains on track to reach its goal of reaching break-even or profitability within its current operations in 2024. Edible Garden AG Incorporated (NASDAQ: EDBL) gained 112% to $9.73 after the company reported preliminary first quarter FY24 results. Sintx Technologies, Inc. (NASDAQ: SINT) jumped 53% to $0.0350. VIA optronics AG (NYSE: VIAO) shares gained 50.4% to $0.3924 after dipping over 15% on Tuesday. AERWINS Technologies Inc. (NASDAQ: AWIN) jumped 42.2% to $4.70. The Children's Place, Inc. (NASDAQ: PLCE) climbed 35.5% to $9.64 after the company announced it entered into a new financing agreement with Mithaq Capital. Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) gained 32% to $5.38 after the company announced that it submitted three proposals since February to acquire all of the outstanding shares of common stock of Vanda Pharmaceuticals and confirmed that its most recent proposal to acquire Vanda remains open for Vanda and its Board of Directors to consider. EZGO Technologies Ltd. (NASDAQ: EZGO) gained 28% to $2.20. EZGO entered into a strategic cooperation framework agreement with Woteam to jointly explore the Southeast Asian Market. CXApp Inc. (NASDAQ: CXAI) shares rose 25% to $4.89 after the company announced 24% ARR growth in 2023. TRACON Pharmaceuticals, Inc. (NASDAQ: TCON) rose 19.6% to $2.0461. WiSA Technologies, Inc. (NASDAQ:

U.S. stocks traded higher this morning, with the Dow Jones index gaining around 200 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.55% to 38,006.47 while the NASDAQ rose 0.24% to 15,903.38. The S&P 500 also rose, gaining, 0.40% to 5,071.74. Check This Out: Alphabet, Toll Brothers And 2 Other Stocks Insiders Are Selling Leading and Lagging Sectors Materials shares rose by 1% on Wednesday. In trading on Wednesday, real estate shares fell by 0.3%. Top Headline Abbott Laboratories (NYSE: ABT) reported better-than-expected earnings for its first quarter. The company posted first-quarter sales of $9.96 billion, up 10.8% on an organic basis for the underlying base business, beating the consensus of $9.88 billion. Abbott’s adjusted diluted earnings per share was 98 cents, beating the analyst estimates of 95 cents. Equities Trading UP INVO Bioscience, Inc. (NASDAQ: INVO) shares shot up 203% to $2.35 after the company reported a ...

Shares of INVO Bioscience, Inc. (NASDAQ: INVO) rose sharply in today’s pre-market trading after reporting fourth-quarter results. The company said quarterly revenue surged 397% year-over-year to $1,381,754, from $278,142 in the year-ago period, according to data from Benzinga Pro. INVO Bioscience shares jumped 73.1% to $1.35 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers Mobile Global Esports Inc. (NASDAQ: MGAM) shares gained 36.1% to $0.1565 in pre-market trading after falling around 9% on Tuesday. On April 16, Maxim Group analyst Jack Vander Aarde downgraded Mobile Global Esports from Buy to Hold. Chromocell Therapeutics Corporation (NYSE: CHRO) gained 29.1% to $2.35 in pre-market trading after falling around 7% on Tuesday. Clene Inc. (NASDAQ: CLNN) gained 27.9% to $0.3965 in pre-market trading after the company announced Phase 2 VISIONARY-MS long term extension study results at the 2024 American Academy of Neurology Annual Meeting. VIA optronics AG (NYSE: VIAO) shares ...

Gainers NeoGames S.A. (NASDAQ: NGMS) shares surged 121% to $28.38 in pre-market trading as the company agreed to be acquired by Aristocrat Leisure Limited for $29.50 per share in cash. MGO Global, Inc. (NASDAQ: MGOL) shares rose 60.2% to $1.91 in pre-market trading. MGO Global is scheduled to host a webcast on May 16, 2023 to discuss recent operational developments and financial results for the first quarter. Aligos Therapeutics, Inc. (NASDAQ: ALGS) shares gained 45% to $1.58 in pre-market trading after the company reported a Research collaboration and development agreement with Xiamen Amoytop Biotech Co. Ltd. for the use of Aligos’ oligonucleotide platform for the treatment of liver diseases. GSI Technology, Inc. (NASDAQ: GSIT) shares gained 31% to $6.67 in pre-market trading after jumping 210% on Friday. Peraso Inc. (NASDAQ: PRSO) shares rose 30.2% to $0.47 in pre-market trading. Peraso is expected to release its first-quarter financial ...